<i>In vitro</i> evaluation of lipidic nanocarriers for mebendazole delivery to improve anticancer activity
MBZ-NLCs exhibit significantly improved stability, EE%, and anticancer activity compared to free MBZ. These promising results suggest that MBZ-NLCs could be a potent therapeutic approach for lung cancer treatment, warranting further <i>in vivo</i> studies and exploration of different administration routes.
Authors
- Hamdi Nsairat (ORCID: https://orcid.org/0000-0001-5916-5879)
- Mohamed El‐Tanani (ORCID: https://orcid.org/0000-0002-4735-5445)
- Maria‐Luisa Tamma
- Razan Madi (ORCID: https://orcid.org/0000-0002-0103-1058)
Institutions
- Al-Ahliyya Amman University (JO)
- Ras al-Khaimah Medical and Health Sciences University (AE)
Publication Details
- Journal
- Drug Development and Industrial Pharmacy
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1080/03639045.2024.2428405
- Citations
- 8
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 1.39